AMG 487
CAS No. 473719-41-4
AMG 487( —— )
Catalog No. M22838 CAS No. 473719-41-4
AMG 487 prevents the chemokines I-IP-10 and I-ITAC from binding to CXCR3.?In the cellular assays, AMG 487 inhibits CXCR3-mediated cell migration with IC50 values of 8nM, 15nM and 36nM for I-IP-10, I-ITAC and MIG, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 63 | In Stock |
|
| 5MG | 105 | In Stock |
|
| 10MG | 150 | In Stock |
|
| 25MG | 254 | In Stock |
|
| 50MG | 376 | In Stock |
|
| 100MG | 556 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAMG 487
-
NoteResearch use only, not for human use.
-
Brief DescriptionAMG 487 prevents the chemokines I-IP-10 and I-ITAC from binding to CXCR3.?In the cellular assays, AMG 487 inhibits CXCR3-mediated cell migration with IC50 values of 8nM, 15nM and 36nM for I-IP-10, I-ITAC and MIG, respectively.
-
DescriptionAMG 487 prevents the chemokines I-IP-10 and I-ITAC from binding to CXCR3.?In the cellular assays, AMG 487 inhibits CXCR3-mediated cell migration with IC50 values of 8nM, 15nM and 36nM for I-IP-10, I-ITAC and MIG, respectively.AMG487 is a small molecular weight antagonist of CXCR3.?66.1 tumor cells were pretreated with AMG487 prior to i.v. injection into immune-competent female mice.?Antagonism of CXCR3 on 66.1 tumor cells inhibited experimental lung metastasis, and this antimetastatic activity was compromised in mice depleted of natural killer cells.?Systemic administration of AMG487 also inhibited experimental lung metastasis.?In contrast to the antimetastatic effect of AMG487, local growth of 66.1 mammary tumors was not affected by receptor antagonism. Murine mammary tumor cells express CXCR3 which facilitates the development of lung metastases.Indicate for the first time that a small molecular weight antagonist of CXCR3 has the potential to inhibit tumor metastasis.AMG487, a small molecular weight antagonist.?In vivo, systemic CXCR3 antagonism by preventive or curative treatments with AMG487 markedly inhibited the implantation and the growth of human and mouse CRC cells within lung without affecting that in the liver.?In addition, we measured increased levels of CXCR3 and ligands expression within lung nodules compared with liver tumours.?Activation of CXCR3 receptors by its cognate ligands facilitates the implantation and the progression of CRC cells within lung tissues and that inhibition of this axis decreases pulmonary metastasis of CRC in two murine tumour models.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetCXCR
-
RecptorCXCR3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number473719-41-4
-
Formula Weight603.59
-
Molecular FormulaC32H28F3N5O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:41 mg/mL (67.93 mM);H2O:< 0.1 mg/mL (insoluble)
-
SMILESO=C(N([C@@H](C1=NC2=NC=CC=C2C(N1C3=CC=C(OCC)C=C3)=O)C)CC4=CC=CN=C4)CC5=CC=C(OC(F)(F)F)C=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
CXCL-CXCR1/2-IN-1
CXCL-CXCR1/2-IN-1 is an orally active and potent inhibitor of the ELR+CXCL-CXCR1/2 pathway with anticancer and anti-angiogenic activity and can be used to study cardiovascular disease and cancer.
-
Eldelumab
Eldelumab (BMS-936557) is a humanized anti-IP-10 IgG type 1 monoclonal antibody with inhibitory activity against CXCL10. It has anti-inflammatory properties, selectively binds to CXCL10, and can be used in the study of rheumatoid arthritis, ulcerative colitis, and Crohn's disease.
-
Syringaresinol-di-O-...
1. Syringaresinol-di-O-glucoside protects the animals from the stress-induced decreases in sex behaviours and in rectal temperature, the stress-induced failure of retrieval of memory, and the stress-induced enlargement of adrenal gland.
Cart
sales@molnova.com